Penumbra, Inc. (PEN)

206,51 +0,81 (+0,39%) In data: 12:49PM EDT. Mercato aperto.

Penumbra, Inc.

One Penumbra Place
Alameda, CA 94502
United States
510 748 3200
https://www.penumbrainc.com

Settore/i: Healthcare
Settore: Medical Devices
Impiegati a tempo pieno: 4.200

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Adam Elsesser	Co-Founder, Chairman, President & CEO	601,62k	3,66M	1962
Dr. Arani Bose M.D.	Co-Founder & Director	37,5k	N/D	1962
Ms. Maggie S. Yuen	Chief Financial Officer	660,98k	N/D	1973
Mr. Lambert Shiu	Chief Accounting Officer	539,15k	269,12k	1981
Ms. Johanna Roberts	Executive VP, General Counsel & Secretary	655,75k	4,61M	1972
Mr. Ben Sorci	Executive Vice President of Operations	N/D	N/D	N/D
Mr. Pankaj Tiwari	Executive VP & Chief Information Officer	N/D	N/D	N/D
Ms. Jee Hamlyn-Harris	Investor Relations Officer	N/D	N/D	N/D
Mr. Ben Tompkins	Executive Vice President of Development	N/D	N/D	N/D
Ms. Gita Barry	President of Immersive Healthcare	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2022 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Governance aziendale

L'ISS Governance QualityScore di Penumbra, Inc. al 1 aprile 2024 è 7. I criteri di valutazione fondamentali sono revisione: 9; Consiglio di Amministrazione: 6; diritti degli azionisti: 7; retribuzione: 7.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.